Core Laboratories (CLB) Change in Accured Expenses (2022 - 2026)

Core Laboratories' Change in Accured Expenses history runs 5 years deep, the most recent figure standing at -$845000.0 for Q1 2026.

• On a quarterly basis, Change in Accured Expenses rose 19.75% year-over-year to -$845000.0 in Q1 2026; TTM through Mar 2026 was -$2.5 million, a 260.86% decrease from a year earlier, with the FY2025 full-year figure at -$2.7 million, down 207.11% from the prior year.
• Change in Accured Expenses declined to -$845000.0 in Q1 2026 per CLB's latest filing, from $659000.0 in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $3.5 million in Q4 2023 and bottomed at -$5.7 million in Q4 2022.
• The 5-year median for Change in Accured Expenses is -$78000.0 (2024), against an average of -$773600.0.
• Across the five-year window, Change in Accured Expenses surged 162.05% in 2023 and sank 1250.0% in 2025, its largest moves.
• Year by year, Change in Accured Expenses stood at -$5.7 million in 2022, then surged by 162.05% to $3.5 million in 2023, then sank by 71.68% to $1.0 million in 2024, then sank by 34.43% to $659000.0 in 2025, then tumbled by 228.22% to -$845000.0 in 2026.
• Per Business Quant, the three latest CLB Change in Accured Expenses figures stand at -$845000.0 (Q1 2026), $659000.0 (Q4 2025), and -$2.5 million (Q3 2025).